• About Us
    • Contact Us
    • Login
    • ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • #GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
About Us Contact Us Login ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • 0 CME Hours
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • #GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
#Grand Rounds

Drink Your Milk! Is Greater Dairy Intake Linked to Increased or Decreased Mortality and Cardiovascular Disease?

image_pdfFavoriteLoadingFavorite

BACKGROUND AND PURPOSE:

  • Many dietary guidelines recommend against whole fat dairy products to avoid saturated fats
    • Data is limited to justify these recommendations
    • Dairy products and fat also contain beneficial products such as specific amino acids, unsaturated and branched-chain fats, natural trans fats, vitamin K1 and K2, and calcium
  • Dehghan et al. (The Lancet, 2018) sought to determine whether total dairy and specific types of dairy products are associated with mortality and major cardiovascular disease

METHODS:

  • The Prospective Urban Rural Epidemiology (PURE) study is a large multinational cohort study of individuals 35-70 years old
  • Dietary intake of dairy products was recorded using a country-specific validated food frequency questionnaire
    • Also grouped in to low and whole fat
  • Dairy produces were milk, yoghurt, and cheese, stratified by fat content
  • Primary outcome
    • Composite of mortality or major cardiovascular events
    • Major cardiovascular events defined as fatal and non-fatal myocardial infarction, fatal and non-fatal strokes, heart failure, and cardiovascular mortality

RESULTS:

  • Dietary intake was recorded from 136,384 people in 21 countries
    • 10,567 composite events (deaths and major cardiovascular events) were recorded
    • 9.1 years of follow-up
  • Compared with no intake, > 2 servings a day of total dairy was associated with lower risk of
    • Composite outcome (Hazard Ratio [HR] 0·84; 95% CI 0·75–0·94; ptrend=0·0004)
    • Total mortality (HR 0·83; 95% CI, 0·72–0·96; ptrend=0·0052)
    • Non-cardiovascular mortality (HR 0·86, 95% CI, 0·72–1·02; ptrend=0·046)
    • Cardiovascular mortality (HR 0·77; 95% CI, 0·58–1·01; ptrend=0·029)
    • Major cardiovascular disease (HR 0·78, 95% CI, 0·67–0·90; ptrend=0·0001)
    • Stroke (HR 0·66, 95% CI, 0·53–0·82; ptrend=0·0003)
    • No significant association with myocardial infarction was observed
    • Similar associations were observed for whole-fat and low-fat dairy
  • Compared to no intake, > 1 servings a day of milk and yogurt was associated with lower risk of composite outcome
    • Milk = HR 0·90: 95% CI, 0·82–0·99; ptrend=0·0529
    • Yoghurt = HR 0·86; 95% CI, 0·75–0·99; ptrend=0·0051
  • Cheese intake was not significantly associated with the composite outcome (HR 0·88, 95% CI, 0·76–1·02; ptrend=0·1399)
  • Butter intake was not significantly associated with clinical outcomes (HR 1·09, 95% CI 0·90–1·33; ptrend=0·4113)
  • In the group that only ate whole-fat dairy, higher intake (>2 services compared to <0.5 servings/day) of total dairy was associated with lower risk for
    • Composite outcome: HR 0·71; 95% CI, 0·60–0·83 (ptrend=0·0001)
    • Total mortality: HR 0·75; 95% CI, 0·60–0·92 (ptrend=0·015),
    • Major cardiovascular disease: HR 0·68; 95% CI, 0·56–0·84 (ptrend=0·0001)
  • Results were consistent across regions

CONCLUSION:

  • At least 1 serving of dairy a day was associated with lower cardiovascular disease risk and mortality, especially stroke
  • These findings contradict guidelines but are consistent with observational studies and RCTs
  • Authors suggest against discouraging consumption of dairy products

Learn More – Primary Sources:

Association of dairy intake with cardiovascular disease and mortality in 21 countries from five continents (PURE): a prospective cohort study

image_pdfFavoriteLoadingFavorite

< Previous
All #Grand Rounds Posts
Next >

Related ObG Topics:

Cochrane Review: Do Omega-3 Fatty Acids Reduce Cardiovascular Disease? 
PURE Study Results – Carbs vs Fat Intake to Reduce Cardiovascular Morbidity and Mortality?
More From the PURE Study: Does Type of Exercise Matter When it Comes to Decreasing Mortality and CVD?  
Does Diclofenac Introduce a Disproportionate risk for Cardiovascular Disease?

Sections

  • COVID-19
  • Alerts
  • OB
  • GYN
    • GYN
    • Sexual Health
  • 2T US Atlas
  • The Genome
  • Primary Care
  • Your Practice
  • #Grand Rounds
  • My Bookshelf
  • Now@ObG
  • Media

ObG Library

  • Hysteroscopy
  • Fertility
  • Site Map/
  • © ObG Project/
  • Terms and Conditions/
  • Privacy/
  • Contact Us/
© ObG Project
SSL Certificate


  • Already an ObGFirst Member?
    Welcome back

    Log In

    Want to sign up?
    Get guideline notifications
    CME Included

    Sign Up

Get Guideline Alerts Direct to Your Phone
Try ObGFirst Free!

Sign In

Lost your password?

Sign Up for ObGFirst and Stay Ahead

  • - Professional guideline notifications
  • - Daily summary of a clinically relevant
    research paper
  • - Includes 1 hour of CME every month

ObGFirst Free Trial

Log In to ObG First

Please log in to access OBGFirst and the 2T Ultrasound Atlas

Password Trouble?

Sign Up for ObGFirst

  • - Access 2T US Atlas
  • - Guideline notifications
  • - Daily research paper summaries
  • - And lots more!

ObG First Free Trial

Media - Internet

Computer System Requirements

OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Jointly provided by

NOT ENOUGH CME HOURS

It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan

Subscribe

JOIN OBGFIRST AND GET CME/CE CREDITS

One of the benefits of an ObGFirst subscription is the ability to earn CME/CE credits from the ObG entries you read. Tap the button to learn more about ObGFirst

Learn More
Leaving ObG Website

You are now leaving the ObG website and on your way to PRIORITY at UCSF, an independent website. Therefore, we are not responsible for the content or availability of this site